Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/43038
Campo DC Valoridioma
dc.contributor.authorOrdoñez, R.
dc.contributor.authorHenríquez-Hernández, L. A.
dc.contributor.authorFederico, M.
dc.contributor.authorValenciano, A.
dc.contributor.authorPinar, B.
dc.contributor.authorLloret, M.
dc.contributor.authorBordón, E.
dc.contributor.authorRodríguez-Gallego, C.
dc.contributor.authorLara, P. C.
dc.date.accessioned2018-11-21T12:12:37Z-
dc.date.available2018-11-21T12:12:37Z-
dc.date.issued2014
dc.identifier.issn0179-7158
dc.identifier.urihttp://hdl.handle.net/10553/43038-
dc.description.abstractBackground and purpose. A close relationship exists between immune response and tumor behavior. This study aimed to explore the associations between radiation-induced apoptosis (RIA) in peripheral blood lymphocytes (PBL) and clinical pathological variables. Furthermore, it assessed the role of RIA as a prognostic factor for survival in cervical carcinoma patients.Patients and methods. Between February 1998 and October 2003, 58 consecutive patients with nonmetastatic, localized stage I-II cervical carcinoma who had been treated with radiotherapy (RT) +/- A chemotherapy were included in this study. Follow-up ended in January 2013. PBL subpopulations were isolated and irradiated with 0, 1, 2 and 8 Gy then incubated for 24, 48 and 72 h. Apoptosis was measured by flow cytometry and the beta value, a parameter defining RIA of lymphocytes, was calculated.Results. Mean follow-up duration was 111.92 +/- 40.31 months. Patients with lower CD8 T lymphocyte beta values were at a higher risk of local relapse: Exp(B) = 5.137, confidence interval (CI) 95 % = 1.044-25.268, p = 0.044. Similar results were observed for regional relapse: Exp(B) = 8.008, CI 95 % = 1.702-37.679, p = 0.008 and disease relapse: Exp(B) = 6.766, CI 95 % = 1.889-24.238, p = 0.003. In multivariate analysis, only the CD8 T lymphocyte beta values were found to be of prognostic significance for local disease-free survival (LDFS, p = 0.049), regional disease-free survival (RDFS, p = 0.002), metastasis-free survival (MFS, p = 0.042), disease-free survival (DFS, p = 0.001) and cause-specific survival (CSS p = 0.028).Conclusion. For the first time, RIA in CD8 T lymphocytes was demonstrated to be a predictive factor for survival in cervical carcinoma patients.
dc.publisher0179-7158
dc.relation.ispartofStrahlentherapie und Onkologie
dc.sourceStrahlentherapie und Onkologie[ISSN 0179-7158],v. 190, p. 210-216
dc.subject.otherGrowth-Factor-Beta
dc.subject.otherClinical Toxicity
dc.subject.otherCancer Patients
dc.subject.otherTgf-Beta
dc.subject.otherRadiation
dc.subject.otherCells
dc.subject.otherHypoxia
dc.subject.otherTumor
dc.subject.otherExpression
dc.subject.otherPrediction
dc.titleRadio-induced apoptosis of peripheral blood CD8 T lymphocytes is a novel prognostic factor for survival in cervical carcinoma patients
dc.typeinfo:eu-repo/semantics/Articlees
dc.typeArticlees
dc.identifier.doi10.1007/s00066-013-0488-x
dc.identifier.scopus84893797725-
dc.identifier.isi000330623000011
dc.contributor.authorscopusid37261658100
dc.contributor.authorscopusid15829708200
dc.contributor.authorscopusid57201785606
dc.contributor.authorscopusid55382811900
dc.contributor.authorscopusid54904204300
dc.contributor.authorscopusid6507421079
dc.contributor.authorscopusid7003855087
dc.contributor.authorscopusid24402677200
dc.contributor.authorscopusid6602114379
dc.contributor.authorscopusid7004374085
dc.description.lastpage216
dc.description.firstpage210
dc.relation.volume190
dc.type2Artículoes
dc.contributor.daisngid2115479
dc.contributor.daisngid465624
dc.contributor.daisngid29956480
dc.contributor.daisngid13991533
dc.contributor.daisngid1285881
dc.contributor.daisngid802813
dc.contributor.daisngid34952053
dc.contributor.daisngid2045042
dc.contributor.daisngid591076
dc.contributor.wosstandardWOS:Ordonez, R
dc.contributor.wosstandardWOS:Henriquez-Hernandez, LA
dc.contributor.wosstandardWOS:Federico, M
dc.contributor.wosstandardWOS:Valenciano, A
dc.contributor.wosstandardWOS:Pinar, B
dc.contributor.wosstandardWOS:Lloret, M
dc.contributor.wosstandardWOS:Bordon, E
dc.contributor.wosstandardWOS:Rodriguez-Gallego, C
dc.contributor.wosstandardWOS:Lara, PC
dc.date.coverdateFebrero 2014
dc.identifier.ulpgces
dc.description.sjr1,099
dc.description.jcr2,914
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGIR IUIBS: Medio Ambiente y Salud-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0003-3237-0316-
crisitem.author.orcid0000-0002-4344-8644-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameHenríquez Hernández, Luis Alberto-
crisitem.author.fullNameBordón Rodríguez, Elisa de los Reyes-
crisitem.author.fullNameRodríguez Gallego, José Carlos-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

15
actualizado el 21-abr-2024

Citas de WEB OF SCIENCETM
Citations

14
actualizado el 25-feb-2024

Visitas

27
actualizado el 08-jul-2023

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.